Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKAA2 | P54646 | 1/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | HMGCR | P04035 | 2/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 1/20 | 0.39 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GCGR | P47871 | 3/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30060873 | 1.00 | PRKAA2 (1.00) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL10152972 | 0.88 | PRKAA2 (0.78) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL29419156 | 0.87 | PRKAA2 (0.77) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL29419455 | 0.87 | PRKAA2 (0.77) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL14749820 | 0.87 | PRKAA2 (0.77) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL3709827 | 0.87 | PRKAA2 (0.77) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL14753495 | 0.87 | PRKAA2 (0.77) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL24454 | 0.87 | PRKAA2 (0.77) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL27936537 | 0.86 | PRKAA2 (0.76) | PRKAA2RXRANR1I2NR4A2PDE4D | |
| SCHEMBL30595115 | 0.86 | PRKAA2 (0.74) | PRKAA2RXRANR1I2NR4A2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109867695-B | Novel preparation method of pitavastatin calcium intermediate | 上虞京新药业有限公司 | 2021-09-17 | — | — | CN | claimed |
| CN-103483252-B | Synthetic method of 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolylmethanol | YELLOW RIVER DELTA JINGBO RES INST CHEMICAL IND CO LTD | 2015-07-22 | — | — | CN | claimed |
| CN-104072415-A | Preparation method of pitavastatin calcium | NANTONG CHANGYOU PHARMACEUTICAL SCIENCE & TECHNOLOGY CO LTD | 2014-10-01 | — | — | CN | claimed |
| CN-103508948-A | Method for preparing pitavastatin calcium | ASYMCHEM LAB TIANJIN CO LTD | 2014-01-15 | — | — | CN | claimed |
| CN-103508947-A | Preparation method of pitavastatin calcium | WEIHAI WEITAI PHARMACEUTICAL TECHNOLOGY DEV CO LTD | 2014-01-15 | — | — | CN | claimed |
| CN-103483252-A | Synthetic method of 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolylmethanol | YELLOW RIVER DELTA JINGBO RES INST CHEMICAL IND CO LTD | 2014-01-01 | — | — | CN | claimed |
| EP-2387561-A2 | IMPROVED PROCESS FOR THE PREPARATION OF HIGHLY PURE (3R,5S)-7-Ý2-CYCLOPROPYL-4-(4-FLUOROPHENYL) QUINOLIN-3-YL¨-3,5-DIHYDROXY-6(E)-HEPTENOIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | MSN Laboratories Limited (IN) | 2011-11-23 | — | — | EP | claimed |
| WO-2010089770-A2 | IMPROVED PROCESS FOR THE PREPARATION OF HIGHLY PURE (3R,5S)-7-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL) QUINOLIN-3-YL]-3,5-DIHYDROXY-6(E)-HEPTENOIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | MSN LABORATORIES LIMITED (IN) | 2010-08-12 | — | — | WO | claimed |
| CN-100445267-C | Process for preparing 4-(4-fluoro-phenyl)-3- hydroxymethyl-2- cyclopropyl-quinoline | SHANGHAI INST PHARM INDUSTRY (CN) | 2008-12-24 | — | — | CN | claimed |
| CN-1951920-A | Process for preparing 4-(4-fluoro-phenyl)-3- hydroxymethyl-2- cyclopropyl-quinoline | SHANGHAI INST PHARM INDUSTRY (CN) | 2007-04-25 | — | — | CN | claimed |
| CN-1193989-C | preparation method of quinoline formaldehyde | NISSAN CHEMICAL IND LTD (JP) | 2005-03-23 | — | — | CN | claimed |
| US-6437135-B1 | OXIDIZING 2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYLQUINOLINE WITH A HYPOHALOGENOUS ACID SALT AND A QUATERNARY AMMONIUM SALT TO PRODUCE 2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-QUINOLINE-3-CARBALDEHYDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2002-08-20 | — | — | US | claimed |
| CN-1333752-A | preparation method of quinoline formaldehyde | NISSAN CHEMICAL IND LTD (JP) | 2002-01-30 | — | — | CN | claimed |
| EP-1142876-A1 | PROCESS FOR PRODUCING QUINOLINECARBALDEHYDE | Nissan Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | claimed |
| JP-8027114-A | — | — | None | — | — | JP | disclosed |
| CN-111747978-B | Silicon-center chiral tetra-substituted silane and preparation method thereof | 南方科技大学 | 2023-01-03 | — | — | CN | disclosed |
| CN-109867695-B | Novel preparation method of pitavastatin calcium intermediate | 上虞京新药业有限公司 | 2021-09-17 | — | — | CN | disclosed |
| JP-H0827114-A | MANUFACTURE OF QUINOLINECARBOALDEHYDE | SUMIKA FINE CHEM KK | 1996-01-30 | — | — | JP | disclosed |
| WO-1995011898-A1 | CONDENSED PYRIDINE TYPE MEVALONOLACTONE INTERMEDIATE AND PROCESS FOR ITS PRODUCTION | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1995-05-04 | — | — | WO | disclosed |
| JP-H00827114-A | — | — | 0001-01-01 | — | — | JP | disclosed |